# OnCo record avenzo (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/avenzo/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "avenzo" ;
  schema:name "Avenzo Therapeutics"@en ;
  schema:description "Avenzo in-licenses Chinese assets, including the Nectin-4×TROP2 bispecific ADC AVZO-103 and a CDK2 inhibitor."@en ;
  schema:url <https://onco.cc/companies/avenzo/>, <https://www.avenzotx.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.avenzotx.com> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/nectin4/>, <https://onco.cc/targets/trop2/> ;
  onco:drugs <https://onco.cc/drugs/avzo-021/>, <https://onco.cc/drugs/avzo-023/> ;
  onco:trials <https://onco.cc/trials/nct05867251/>, <https://onco.cc/trials/nct07193511/>, <https://onco.cc/trials/nct07038343/> .